• Nie Znaleziono Wyników

Estimated breast cancer risk and screening outcomes among premenopausal women with non-cyclic mastalgia

N/A
N/A
Protected

Academic year: 2022

Share "Estimated breast cancer risk and screening outcomes among premenopausal women with non-cyclic mastalgia"

Copied!
4
0
0

Pełen tekst

(1)

© P o l s k i e T o w a r z y s t w o G i n e k o l o g i c z n e Nr 09/2013

754

P R A C E O R Y G I N A L N E ginekologia

+MRIOSP4SP

Estimated breast cancer risk and screening outcomes among premenopausal women with non-cyclic mastalgia

Szacowane ryzyko raka sutka oraz wyniki badań skriningowych u przedmenopauzalnych kobiet z niecykliczną mastalgią

/HFK5RJXOVNL-DQ%LĔF]\N

“Medyk-Centrum” Private Medical Center, Gynecology and Breast Diseases Clinic, Czestochowa, Poland

Abstract

Objectives: Breast pain is a common but worrisome symptom, which can cause a significant psychological bur- den of cancer stress. It is not known whether breast cancer risk estimation models can be used as an adjunct to the clinical and radiological assessment in counseling women with mastalgia. The aim of our study was to compare the estimated breast cancer risk and screening outcomes between patients with mastalgia and women requesting prophylactic examinations.

Material and methods: 112 premenopausal women with non-cyclic breast pain and 182 control women who presented for prophylactic examination were screened with mammography and ultrasound. Breast cancer risk esti- mated with the Gail and Tyrer-Cuzick models along with screening outcomes were compared between the groups.

Results: Premenopausal patients with mastalgia had lower estimated breast cancer risk than controls. The dif- ference was observed with both the Gail and Tyrer-Cuzick models (Gail 5-year risk: 0.66 ± 0.4% vs. 0.77 ± 0.4%, p=0.0002; Tyrer-Cuzick 5-year risk: 0.85 ± 0.4% vs. 0.95 ± 0.3%, p=0.002; Gail lifetime risk: 8.98 ± 3.6% vs. 9.6 ± 3.9%, p=0.015; Tyrer-Cuzick lifetime risk: 8.3 ± 3.1 % vs. 8.9 ± 2.7 %, p=0.045). Radiological and clinical outcomes were comparable between the groups.

Conclusions: Breast pain was associated with lower estimated breast cancer risk but had no effect on screening outcomes in the study population.

Keywords: breast cancer / breast pain / risk assessment / statistical models /

Otrzymano: 05.11.2012

Zaakceptowano do druku: 10.06.2013 Adres do korespondencji:

Lech Rogulski

“Medyk-Centrum” Private Medical Center, Gynecology and Breast Diseases Clinic, Czestochowa, Poland, 42-200 Czestochowa, al. Wolności 34

tel. +48 34 654666; fax.: +48 34 3683430 e-mail: lech.rogulski@gmail.com

(2)

© P o l s k i e T o w a r z y s t w o G i n e k o l o g i c z n e

Nr 09/2013

755

P R A C E O R Y G I N A L N E ginekologia +MRIOSP4SP

Lech Rogulski, Jan Bińczyk. Estimated breast cancer risk and screening outcomes among premenopausal women with non-cyclic mastalgia.

Introduction

(SLGHPLRORJLFDO PRGHOV IRU EUHDVW FDQFHU ULVN HVWLPDWLRQ

DUHSURYHQDQGUHOLDEOHWRROVIRULGHQWL¿FDWLRQRIZRPHQZKRDUH

PRUHOLNHO\WRGHYHORSEUHDVWFDQFHUDQGPD\UHTXLUHDGGLWLRQDO

VFUHHQLQJPHDVXUHVRUSUHYHQWLYHLQWHUYHQWLRQV>@+RZHYHU

WKH\ KDYH QRW \HW EHHQ XVHG DV DQ DGMXQFW WR WKH FOLQLFDO DQG

UDGLRORJLFDO DVVHVVPHQW LQ FRXQVHOLQJ ZRPHQ ZLWK FRPPRQ

EUHDVWV\PSWRPVVXFKDVPDVWDOJLD

Objective

7KHDLPRIRXUVWXG\ZDVWRHVWDEOLVKZKHWKHUSUHPHQRSDXVDO

ZRPHQ ZLWK EUHDVW SDLQ KDYH GLIIHUHQW HVWLPDWHG EUHDVW FDQFHU

ULVNDQGVFUHHQLQJRXWFRPHVFRPSDUHGWRDV\PSWRPDWLFZRPHQ

UHTXHVWLQJSURSK\ODFWLFH[DPLQDWLRQ

Materials and methods

&URVVVHFWLRQDO VWXG\  SUHPHQRSDXVDO SDWLHQWV ZKR

SUHVHQWHG WR D EUHDVW GLVHDVHV FOLQLF ZLWK QRQF\FOLF PDVWDOJLD

EHWZHHQ 0D\  DQG 0D\  ZHUH DVVHVVHG FOLQLFDOO\

LQFOXGLQJ FOLQLFDO EUHDVW H[DPLQDWLRQ  DQG VFUHHQHG ZLWK

PDPPRJUDSK\ DQG EUHDVW XOWUDVRXQG PDVWDOJLD JURXS  

SUHPHQRSDXVDO ZRPHQ ZKR SUHVHQWHG LQ WKH VDPH SHULRG IRU

SURSK\ODFWLF H[DPLQDWLRQV XQGHUZHQW LGHQWLFDO SURFHGXUH DQG

ZHUHXVHGDVDFRQWUROJURXS

1RQF\FOLFPDVWDOJLDZDVGH¿QHGDVDORFDOL]HGXQLODWHUDO

RUELODWHUDOEUHDVWSDLQXQUHODWHGWRDPHQVWUXDOF\FOHRIPRUH

WKDQWKUHHPRQWKVLQGXUDWLRQ$GGLWLRQDOLQFOXVLRQFULWHULDZHUH

DJH EHWZHHQ  \HDUV SUHPHQRSDXVDO VWDWXV ZLWK UXOHG RXW

SUHJQDQF\ 3DWLHQWV ZLWK SRVLWLYH SHUVRQDO KLVWRU\ IRU EUHDVW

FDQFHU RU FOLQLFDOO\ SDOSDEOH EUHDVW RU D[LOODU\ OHVLRQV ZHUH

H[FOXGHG IURP WKH VWXG\7KH VWXG\ ZDV DSSURYHG E\ WKH ORFDO

ELRHWKLFDOFRPPLWWHHDQGDOOZRPHQVLJQHGDQLQIRUPHGFRQVHQW

IRUPEHIRUHSDUWLFLSDWLQJ

,QGLYLGXDOEUHDVWFDQFHUULVNZDVFDOFXODWHGIURPWKHPRGL¿HG

*DLO DQG 7\UHU&X]LFN PRGHOV > @ 8OWUDVRXQG H[DPLQDWLRQV

ZHUH SHUIRUPHG XVLQJ $ORND 3UR6RXQG 66' HTXLSSHG

ZLWK  0+] OLQHDU SUREH E\ D J\QHFRORJLVW WUDLQHG LQ EUHDVW

VRQRJUDSK\0DPPRJUDSKLFH[DPLQDWLRQVZHUHSHUIRUPHGXVLQJ

6LHPHQV1RYDWLRQGLJLWDOPDPPRJUDSK\V\VWHPDQGDVVHVVHGE\

WZRLQGHSHQGHQWUDGLRORJLVWV)XUWKHUGLDJQRVWLFDQGWKHUDSHXWLF

VWHSVZHUHSURYLGHGDFFRUGLQJWRQDWLRQDORQFRORJLFDOJXLGHOLQHV

UHJDUGOHVVRIWKHHVWLPDWHGEUHDVWFDQFHUULVN

3HUVRQDO  GHPRJUDSKLF DQG UHSURGXFWLYH  GDWD HVWLPDWHG

EUHDVWFDQFHUULVNUDGLRORJLFDOVWXGLHVUHVXOWVDQGUHOHYDQWFOLQLFDO

RXWFRPHVZHUHFRPSDUHGEHWZHHQWKHJURXSV)LVKHUVH[DFWWHVW

DQG 0DQQ:KLWQH\V 8 WHVW ZHUH XVHG WR FRPSDUH FDWHJRULFDO

DQG FRQWLQXRXV YDULDEOHV UHVSHFWLYHO\ 3YDOXHV OHVV WKDQ 

ZHUHFRQVLGHUHGVWDWLVWLFDOO\VLJQL¿FDQW0XOWLYDULDWHOLQHDUDQG

ORJLVWLF UHJUHVVLRQ ZDV XVHG WR DVFHUWDLQ WKDW HDFK YDULDEOH LV

LQGHSHQGHQWO\VLJQL¿FDQW'DWDZHUHDQDO\]HGZLWK67$7,67,&$

VRIWZDUH 6WDWVRIW,QF  Results

3DWLHQWV ZLWK PDVWDOJLD KDG ORZHU PHDQ HVWLPDWHG EUHDVW

FDQFHU ULVN WKDQ WKH SURSK\ODFWLF JURXS 7KH GLIIHUHQFH ZDV

REVHUYHGZLWKERWK*DLODQG7\UHU&X]LFNPRGHOV3DWLHQWVZLWK

PDVWDOJLDJDYH¿UVWOLYHELUWKVHDUOLHUDQGWKHWLPHVSDQEHWZHHQ

PHQDUFKHDQGWKH¿UVWOLYHELUWKZDVVLJQL¿FDQWO\VKRUWHULQWKDW

JURXS 7KHUH ZHUH QR VLJQL¿FDQW GLIIHUHQFHV LQ RWKHU SHUVRQDO

FKDUDFWHULVWLFVIUHTXHQF\RISRVLWLYHIDPLO\KLVWRU\UDGLRORJLFDO

DQG FOLQLFDO RXWFRPHV 6WXG\ UHVXOWV DUH VXPPDUL]HG LQ Table 1 8OWUDVRXQG H[DPLQDWLRQ GHWHFWHG RQH FDQFHU FDVH PLVVHG E\

PDPPRJUDSK\LQWKHSURSK\ODFWLFJURXS7KUHHRIWKHGHWHFWHG

EUHDVWFDQFHUVZHUHVWDJH,$DQGRQHZDVVWDJH,%

Discussion

%UHDVW SDLQ LV WKH PRVW FRPPRQ EUHDVW V\PSWRP ,WV

SDWKRSK\VLRORJ\LVDVVRFLDWHGSULPDULO\ZLWKHQGRFULQHGLVRUGHUV

EXWWKHGHWDLOVUHPDLQSRRUO\XQGHUVWRRG8SWRRIZRPHQ

H[SHULHQFHUHJXODUSUHPHQVWUXDOGLVFRPIRUWZKLOHDSSUR[LPDWHO\

Streszczenie

Cel pracy: Ból sutków jest częstym, lecz niepokojącym dla kobiety objawem, mogącym powodować lęk o jego potencjalnie nowotworowe przyczyny. Przy klinicznej i radiologicznej ocenie kobiet z mastalgią nie stosowano do tej pory analizy ryzyka raka sutka przy wykorzystaniu modeli statystycznych. Celem naszej pracy było porównanie szacowanego ryzyka raka sutka oraz wyników badań obrazowych pomiędzy pacjentkami z mastalgią a kobietami zgłaszającymi się w celu przeprowadzenia badań profilaktycznych sutków.

Materiał i metody: 112 przedmenopauzalnych pacjentek z niecyklicznym bólem sutków oraz 182 kobiety zgła- szające się do badania profilaktycznego poddano mammografii oraz ultrasonografii sutków. Porównano pomiędzy grupami ryzyko zachorowania na raka sutka oszacowane przy użyciu modelu Gail’a oraz Tyrer-Cuzick’a jak również wyniki badań skriningowych.

Wyniki: Przedmenopauzalne pacjentki z mastalgią miały niższe szacowane ryzyko zachorowania na raka sutka w porównaniu z grupą kontrolną. Różnice obserwowano zarówno dla modelu Gail’a jak i Tyrer-Cuzick’a (5-letnie ryzyko wg Gail’a 0.66 ± 0.4% vs. 0.77 ± 0.4%, p=0.0002; 5-letnie ryzyko wg Tyrer-Cuzick’a: 0.85 ± 0.4% vs. 0.95

± 0.3%, p=0.002; całkowite ryzyko wg Gail’a: 8.98 ± 3.6% vs. 9.6 ± 3.9%, p=0.015; całkowite ryzyko wg Tyrer-Cu- zick’a: 8.3 ± 3.1 % vs. 8.9 ± 2.7 %, p=0.045). Wyniki kliniczne i radiologiczne nie różniły się istotnie.

Wnioski: Ból sutków był związany z niższym szacowanym ryzykiem raka sutka, lecz nie miał wpływu na wyniki badań skriningowych w badanej populacji.

Słowa kluczowe: rak sutka / ból sutka / ocena ryzyka / modele statystyczne /

(3)

© P o l s k i e T o w a r z y s t w o G i n e k o l o g i c z n e Nr 09/2013

756

P R A C E O R Y G I N A L N E

ginekologia +MRIOSP4SP

Lech Rogulski, Jan Bińczyk. Estimated breast cancer risk and screening outcomes among premenopausal women with non-cyclic mastalgia.

 RI ZRPHQ H[SHULHQFH PRGHUDWH WR VHYHUH EUHDVW SDLQ IRU

PRUHWKDQGD\VLQDPRQWK$ERXWKDOIRIWKHZRPHQZLWKVHYHUH

EUHDVWSDLQORRNIRUPHGLFDOKHOS>@6WXGLHVXVLQJ0F*LOOSDLQ

TXHVWLRQQDLUHKDYHVKRZQWKDWEUHDVWSDLQFDQEHDVLQWHQVHDVWKH

V\PSWRPVRIUKHXPDWRLGDUWKULWLVRUPHWDVWDWLFFDQFHU>@:RPHQ

RIWHQLQWHUSUHWEUHDVWSDLQDVDVLJQRIEUHDVWFDQFHU&ODVVLFDOO\

GHVFULEHGEUHDVWFDQFHUSDLQLVRQHVLGHGLQWHQVHDQGRIFRQVWDQW

LQWHQVLW\ ,Q WHUPV RI SUHVHQWDWLRQ LW FRUUHVSRQGV WR QRQF\FOLF

PDVWDOJLD >@$OWKRXJK REVHUYDWLRQDO DQG UHWURVSHFWLYH VWXGLHV

FRQGXFWHG LQ V DVVHVVHG WKDW WKH ULVN RI GHWHFWLQJ EUHDVW

FDQFHU LQ D SDWLHQWZLWK QRQF\FOLFPDVWDOJLDLV EHWZHHQ  DQG

QHZHUVWXGLHV\LHOGHGFRQWUDGLFWRU\UHVXOWV>@'XMLPHW

DOKDYHHYHQVKRZQWKDWSDWLHQWVZLWKEUHDVWSDLQKDYHVOLJKWO\

ORZHUULVNRIGHWHFWLQJFDQFHURQVFUHHQLQJPDPPRJUDSK\WKDQ

DV\PSWRPDWLFZRPHQZKRSUHVHQWIRUSURSK\ODFWLFH[DPLQDWLRQV

YV >@

7KH UHVXOWV RI RXU VWXG\ LQGLFDWHG WKDW EUHDVW SDLQ ZDV

QRW DVVRFLDWHG ZLWK DQ LQFUHDVHG HVWLPDWHG EUHDVW FDQFHU ULVN

DVVHVVHGZLWKWKH*DLODQG7\UHU&X]LFNPRGHOVRUGLIIHUHQFHLQ

VFUHHQLQJRXWFRPHV7KHULVNHVWLPDWHVLQSDWLHQWVZLWKPDVWDOJLD

ZHUH DFWXDOO\ ORZHU WKDQ LQ ZRPHQ UHTXHVWLQJ SURSK\ODFWLF

H[DPLQDWLRQV 7KLV ZDV DWWULEXWDEOH WR D PRUH IDYRUDEOH

Table I. Study results.

Mastalgia Prophylactic P

N 112 182

$JH \HDUV “ “ NS

+HLJKW P “ “ NS

%0, NJP “ “ NS

$JHDWPHQDUFKH \HDUV “ “ NS

$JHDW¿UVWOLYHELUWK \HDUV “ “ #

1XOOLSDULW\     NS

7LPHEHWZHHQPHQDUFKHDQG¿UVWOLYHELUWK

\HDUV “ “ #

3UHYLRXVEUHDVWELRSVLHV     NS

Positive family history for:

%UHDVWFDQFHU WRWDO     NS

UHODWLYH     NS

UHODWLYHV     NS

2YDULDQFDQFHU     NS

Estimated breast cancer risk:

*DLO\HDUULVN “ “ #

*DLOOLIHWLPHULVN “ “ #

7\UHU&X]LFN\HDUULVN “ “ #

7\UHU&X]LFNOLIHWLPHULVN “ “ #

Radiological and clinical outcomes:

0DPPRJUDSKLFDOO\GHQVHEUHDVWV $PHULFDQ

&ROOHJHRI5DGLRORJ\FODVVDQG     NS

)LEURF\VWLFFKDQJHV     NS

6KRUWWHUPIROORZXSQHHGHG     NS

%LRSV\QHHGHG     NS

,QYDVLYHFDQFHUGHWHFWHG     NS

&RQWLQXRXVYDULDEOHVH[SUHVVHGDVPHDQV“VWDQGDUGGHYLDWLRQSURSRUWLRQVH[SUHVVHGDVDEVROXWHYDOXHVDQG

SHUFHQWDJHV

#0DQQ:KLWQH\V8WHVW16QRWVLJQL¿FDQW

(4)

© P o l s k i e T o w a r z y s t w o G i n e k o l o g i c z n e

Nr 09/2013

757

P R A C E O R Y G I N A L N E ginekologia +MRIOSP4SP

Lech Rogulski, Jan Bińczyk. Estimated breast cancer risk and screening outcomes among premenopausal women with non-cyclic mastalgia.

UHSURGXFWLYHKLVWRU\7KHVWXG\ZDVWKH¿UVWWRDVVHVVEUHDVWFDQFHU

ULVNHVWLPDWLRQPRGHOVLQWKHSRSXODWLRQRIZRPHQZLWKEUHDVW

SDLQ,WVUHVXOWVKRZHYHULQGLUHFWO\VWDQGLQOLQHZLWKWKHFLWHG

PRUH UHFHQW VWXGLHV LQGLFDWLQJ WKDW PDVWDOJLD LV QRW DVVRFLDWHG

ZLWKHOHYDWHGEUHDVWFDQFHUULVN,WLVDOVRRQHRIWKH¿UVWVWXGLHV

FRYHULQJWKHDSSOLFDWLRQRIEUHDVWFDQFHUULVNHVWLPDWLRQPRGHOV

LQD3ROLVKSRSXODWLRQ>@

/LPLWDWLRQVDSSO\ZKHQLQWHUSUHWLQJWKHUHVXOWVRIRXUVWXG\,WV

FURVVVHFWLRQDOFKDUDFWHUGRHVQRWDOORZDQ\SUHPLVHRQDEVROXWH

EUHDVWFDQFHUULVNLQSDWLHQWVZLWKPDVWDOJLD,WVFRQFOXVLRQVUHO\

RQ WKH DVVXPSWLRQ WKDW EUHDVW SDLQ LV QRW DQ LQGHSHQGHQW ULVN

IDFWRUIRUEUHDVWFDQFHUDQGUHSUHVHQWVDFURVVSURGXFWRIYDULRXV

UHSURGXFWLYH IDFWRUV LQÀXHQFLQJ EUHDVW HQGRFULQH HQYLURQPHQW

8QWLOVXFKWKHVLVLVFRQ¿UPHGE\SURVSHFWLYHREVHUYDWLRQVEUHDVW

FDQFHU ULVN HVWLPDWLRQ ZLWK HSLGHPLRORJLFDO PRGHOV VKRXOG QRW

GHWHUDWKRURXJKFOLQLFDODQGUDGLRORJLFDODVVHVVPHQWRIZRPHQ

SUHVHQWLQJZLWKEUHDVWSDLQ

Conclusions

%UHDVW SDLQ ZDV DVVRFLDWHG ZLWK ORZHU HVWLPDWHG EUHDVW

FDQFHUULVNEXWKDGQRHIIHFWRQVFUHHQLQJRXWFRPHVLQWKHVWXG\

SRSXODWLRQ

Conflict of interest statement

The authors declare that they have no conflict of interest.

Ethical approval

The study was approved by the bioethical committee of the Polish Mother's Memorial Institute in Lodz, Poland in February, 2009.

References

1. McPherson C, Nissen M. Evaluating a risk-based model for mammographic screening of women in their forties. Cancer. 2002, 94, 2830-2835.

2. Rogulski L, Oszukowski P. Epidemiological models for breast cancer risk estimation. Ginekol Pol. 2011, 82, 451-454.

3. Gail M, Brinton L, Byar D, [et al.]. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989, 81, 1879- 1886.

4. Tyrer J, Duffy S, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Statist Med. 2004, 23, 1111–1130.

5. Mansel R, Webster D, Sweetland H. Breast pain and nodularity. In: Hughes, Mansel & Webster’s Benign Disorders and Diseases of the Breast. 3rd ed. New York: Saunders Elsevier, 2009, 114- 118.

6. Khan S, Apkarian A. The characteristics of cyclical and non-cyclical mastalgia: a prospective study using a modified McGill Pain Questionnaire. Breast Cancer Res Treat. 2002, 75, 147-157.

7. Fariselli G, Lepera P, Viganotti G, [et al.]. Localized mastalgia as presenting symptom in breast cancer. Eur J Surg Oncol. 1988, 14, 213-215.

8. Khan S, Apkarian A. Mastalgia and breast cancer: a protective association? Cancer Detect Prev.

2002, 26, 192-196.

9. Duijm L, Guit G, Hendriks J, [et al.]. Value of breast imaging in women with painful breasts:

observational follow up study. BMJ. 1998, 317, 1492-1495.

10. Pieta B, Samulak D, Opala T, [et al.]. Analysis of odds ratio of increased relative risk of developing breast cancer in different groups of women. Eur J Gynaecol Oncol. 2010, 31, 50-54.

11. Pieta B, Grodecka-Gazdecka S, Chmaj-Wierzchowska K, [et al.]. Analysis of the odds ratio for developing breast cancer in women. Ginekol Pol. 2011, 82, 755-760.

Cytaty

Powiązane dokumenty

Based on the epidemiologic data, in the group of women diagnosed with benign proliferative lesions of the mammary glands with cel- lular atypia and familial aggregation of breast

Występowanie mastalgii, szczególnie cyklicznej, jest silnie powiązane z obrzmieniem piersi [iloraz szans (odds ratio – OR) 29,9; 95-procentowy przedział ufności.. USG,

Engel w 5-letnim badaniu mającym na celu zróżnico- wanie czynników determinujących jakość życia kobiet z nowotworem piersi wykazał, iż dolegliwości związane z

In most European Union (EU) member states (15 out of 28), lung cancer mortality was higher than breast cancer mortality, with either increasing or stable lung cancer mortality

study, which investigated BC tissue from 632 women in terms of presence of steroid receptors, HER2 receptor expression and corelation with age, the most agressive BC

Almost all Polish women would want to be informed about both genetic and anatomical abnormalities and over half of them would consider terminating pregnancy in the case of a severe

Surgical management includes mastectomy or breast-conserving surgery, followed by radiation therapy (younger women have higher local recurrence rates than older women, especially

study, which investigated BC tissue from 632 women in terms of presence of steroid receptors, HER2 receptor expression and corelation with age, the most agressive BC